🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I/II trial investigates the side effects of genetically engineer...
Status
Terminated
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2021-07-19
Trial ID
NCT04639245
The primary objectives of Phase 1A are to evaluate the safety of KITE-718, ...
Status
Terminated
Location
Banner MD Anderson Cancer Center
Start Date
2017-12-27
Trial ID
NCT03139370
Treatments Being Tested
This phase I/II trial studies the side effects of gene-modified immune cell...
Status
Terminated
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2019-07-03
Trial ID
NCT03747484
TCR-T cell therapy experienced a breakthrough for treating tumors in recent...
Status
Unknown
Location
Guangzhou Institute of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University
Start Date
2017-03-21
Trial ID
NCT03029273
Treatments Being Tested
To investigate the safety, tolerability, efficacy and pharmacokinetics of T...
Status
Unknown
Location
Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Start Date
2021-09-07
Trial ID
NCT06054984
Treatments Being Tested
This phase I/IIa trial studies the side effects and best dose of gene-modif...
Status
Active Not Recruiting
Location
Roswell Park Cancer Institute
Start Date
2017-07-14
Trial ID
NCT02650986
This phase I trial studies the side effects and best dose of autologous CD8...
Status
Withdrawn
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2025-04-15
Trial ID
NCT06094842
This is a phase I/Ib study of adoptively transferred T-cell receptor gene-e...
Status
Active Not Recruiting
Location
Providence Portland Medical Center
Start Date
2023-04-03
Trial ID
NCT05349890
Treatments Being Tested
This intermediate-size IND will treat participants with incurable, advanced...
Status
Temporarily Not Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT05389514
Treatments Being Tested
This clinical trial will evaluate the safety and activity of mutant KRAS G1...
Status
Recruiting
Location
Changhai Hospital
Start Date
2021-10-21
Trial ID
NCT04146298